MétaCan
Menu
Back to cohort
Record W4311929040 · doi:10.1002/ijc.34403

Shifting incidence and survival of epithelial ovarian cancer (1995‐2014): A <scp>SurvMark</scp>‐2 study

2022· article· en· W4311929040 on OpenAlexafffundabout
Citadel J. Cabasag, Melina Arnold, Mark J. Rutherford, Jacques Ferlay, Aude Bardot, Eileen Morgan, John Butler, Dianne L. O’Connell, Gregg Nelson, Claus Høgdall, Tine Henrichsen Schnack, Anna Gavin, Mark Elwood, Louise Hanna, Charlie Gourley, Prithwish De, Nathalie Saint‐Jacques, Lina Steinrud Mørch, Ryan Woods, Alon D. Altman, Peter Sykes, Paul A. Cohen, Orla McNally, Bjørn Møller, Patrick Paul Walsh, David Morrison, Freddie Bray, Isabelle Soerjomataram

Bibliographic record

VenueInternational Journal of Cancer · 2022
Typearticle
Languageen
FieldMedicine
TopicOvarian cancer diagnosis and treatment
Canadian institutionsCancerCare ManitobaCanadian Centre for Applied Research in Cancer ControlUniversity of ManitobaNova Scotia Cancer CentreToronto Public HealthCancer Care Nova ScotiaPublic Health OntarioAlberta Cancer FoundationUniversity of Calgary
FundersQueen's UniversityDepartment of Health, Northern IrelandPublic Health AgencyCancer Council VictoriaPartenariat Canadien Contre Le CancerCancer Society of New ZealandKreftforeningenCancer Research UKQueen's University BelfastUniversity of GlasgowPublic Health WalesCancer Institute NSWWorld Health OrganizationKræftens Bekæmpelse
KeywordsEpithelial ovarian cancerIncidence (geometry)Ovarian cancerOncologyMedicineCancerInternal medicineGynecologyBiology

Abstract

fetched live from OpenAlex

The aim of the study is to provide a comprehensive assessment of incidence and survival trends of epithelial ovarian cancer (EOC) by histological subtype across seven high income countries (Australia, Canada, Denmark, Ireland, New Zealand, Norway and the United Kingdom). Data on invasive EOC diagnosed in women aged 15 to 99 years during 1995 to 2014 were obtained from 20 cancer registries. Age standardized incidence rates and average annual percentage change were calculated by subtype for all ages and age groups (15-64 and 65-99 years). Net survival (NS) was estimated by subtype, age group and 5-year period using Pohar-Perme estimator. Our findings showed marked increase in serous carcinoma incidence was observed between 1995 and 2014 among women aged 65 to 99 years with average annual increase ranging between 2.2% and 5.8%. We documented a marked decrease in the incidence of adenocarcinoma "not otherwise specified" with estimates ranging between 4.4% and 7.4% in women aged 15 to 64 years and between 2.0% and 3.7% among the older age group. Improved survival, combining all EOC subtypes, was observed for all ages combined over the 20-year study period in all countries with 5-year NS absolute percent change ranging between 5.0 in Canada and 12.6 in Denmark. Several factors such as changes in guidelines and advancement in diagnostic tools may potentially influence the observed shift in histological subtypes and temporal trends. Progress in clinical management and treatment over the past decades potentially plays a role in the observed improvements in EOC survival.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.084
Threshold uncertainty score0.167

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.002
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.020
GPT teacher head0.338
Teacher spread0.318 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations14
Published2022
Admission routes3
Has abstractyes

Explore more

Same venueInternational Journal of CancerSame topicOvarian cancer diagnosis and treatmentFrench-language works237,207